Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
Top Cited Papers
- 18 May 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 359 (9319), 1734-1739
- https://doi.org/10.1016/s0140-6736(02)08649-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prognostic prediction and treatment strategy in hepatocellular carcinomaJournal of Hepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trialsJournal of Hepatology, 1999
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- Review article: overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis?Alimentary Pharmacology & Therapeutics, 1998
- Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.Gut, 1993
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973